PT  - JOURNAL ARTICLE
AU  - Porter-Stransky, Kirsten A
AU  - Weinshenker, David
TI  - Arresting the Development of Addiction: The Role of β-Arrestin2 in Drug Abuse
DP  - 2017 Jan 01
TA  - Journal of Pharmacology and Experimental Therapeutics
4099  - http://jpet.aspetjournals.org/content/early/2017/03/16/jpet.117.240622.short
4100  - http://jpet.aspetjournals.org/content/early/2017/03/16/jpet.117.240622.full
AB  - The protein β-arrestin2 (βarr2) directly interacts with receptors and signaling pathways that mediate the behavioral effects of drugs of abuse, making it a prime candidate for therapeutic interventions. βarr2 drives desensitization and internalization of G protein-coupled receptors, including dopamine, opioid, and cannabinoid receptors, and can also trigger G protein-independent intracellular signaling. βarr2 mediates several drug-induced behaviors, but the relationship is complex and dependent on the type of behavior (e.g., psychomotor vs. reward), the class of drug (e.g., psychostimulant vs. opioid), and the circuit being interrogated (e.g., brain region, cell type, and specific receptor ligand). Here we discuss the current state of research concerning the contribution of βarr2 to the psychomotor and rewarding effects of addictive drugs. Next we identify key knowledge gaps and suggest new tools and approaches needed to further elucidate the neuroanatomical substrates and neurobiological mechanisms to explain how βarr2 modulates behavioral responses to drugs of abuse, as well as its potential as a therapeutic target.